NCT03214952View on ClinicalTrials.gov

"Drug Use Surveillance of Vonoprazan for Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"

CompletedOBSERVATIONAL

Enrollment

3,183

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions

Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis

Interventions

DRUG

Vonoprazan

Vonoprazan tablets

Trial Locations (1)

Unknown

Takeda Selected Site, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY